All children at risk of serious influenza infection should receive an influenza vaccine. In addition, the extended programme of influenza immunisation for children will involve all 2-4 year old children as well as those in school years 1-6.
The Green Book recommendations (in 2019) are:
- Children with a history of severe anaphylaxis to egg which has previously required intensive care, should be referred for consideration of immunisation in hospital
- All other children with an egg allergy can be safely vaccinated with Fluenz Tetra® in any setting (including primary care and schools)
- Those with both egg allergy and clinical risk factors that contraindicate Live Attenuated Influenza Vaccine (e.g. severe immunosuppression, pregnancy or salicylate therapy) should be offered an inactivated flu vaccine with very low ovalbumin content (≤0.12 μg/mL). These include:
- FluarixTM Tetra
- Quadrivalent Influenza Vaccine (split virion, inactivated)
- Flucelvax® Tetra (from age 9) – a cell based vaccine, containing no ovalbumin (QIVc)